American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$510M |
| 2 |
ExxonMobil
XOM
|
+$222M |
| 3 |
Apple
AAPL
|
+$199M |
| 4 |
CRH
CRH
|
+$189M |
| 5 |
Meta Platforms (Facebook)
META
|
+$183M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$387M |
| 2 |
Colgate-Palmolive
CL
|
+$242M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$235M |
| 4 |
Starbucks
SBUX
|
+$183M |
| 5 |
Equinix
EQIX
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.37% |
| 2 | Financials | 12.82% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 11.43% |
| 5 | Industrials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Joby Aviation
JOBY
$8.17B
| $216K | ﹤0.01% |
42,376
| – | – |
|
2652
Amneal Pharmaceuticals
AMRX
$6.02B
| $212K | ﹤0.01% |
33,314
-192,743
| -85% | -$1.22M |
|
2653
Nurix Therapeutics
NRIX
$2.82B
| $211K | ﹤0.01% |
10,124
-49,942
| -83% | -$778K |
|
2654
Weyco Group
WEYS
$437M
| $210K | ﹤0.01% |
6,912
| – | – |
|
|
KEEL
2655
Keel Infrastructure Corp
KEEL
$2.04B
| $208K | ﹤0.01% |
80,690
-17,063
| -17% | -$36.7K |
|
2656
GameStop
GME
$8.33B
| $207K | ﹤0.01% |
+8,366
| New | +$166K |
|
2657
AeroVironment
AVAV
$9.59B
| $206K | ﹤0.01% |
+1,133
| New | +$204K |
|
2658
Caribou Biosciences
CRBU
$160M
| $205K | ﹤0.01% |
125,029
+16,530
| +15% | +$52.8K |
|
2659
Syndax Pharmaceuticals
SNDX
$1.7B
| $201K | ﹤0.01% |
+9,803
| New | +$205K |
|
|
NNDM
2660
Nano Dimension
NNDM
$348M
| $201K | ﹤0.01% |
91,429
| – | – |
|
2661
ReposiTrak
TRAK
$158M
| $200K | ﹤0.01% |
+13,054
| New | +$210K |
|
2662
Blink Charging
BLNK
$87.1M
| $200K | ﹤0.01% |
72,840
+28,265
| +63% | +$80.7K |
|
2663
Solid Biosciences
SLDB
$974M
| $196K | ﹤0.01% |
34,557
+9,853
| +40% | +$88.2K |
|
2664
Sutro Biopharma
STRO
$353M
| $196K | ﹤0.01% |
6,681
-681
| -9% | -$26.9K |
|
2665
QuickLogic
QUIK
$230M
| $196K | ﹤0.01% |
18,841
+3,750
| +25% | +$47.3K |
|
2666
Pitney Bowes
PBI
$2.28B
| $195K | ﹤0.01% |
38,427
+27
| +0.1% | +$129 |
|
2667
Pyxis Oncology
PYXS
$191M
| $193K | ﹤0.01% |
58,252
+20,901
| +56% | +$87.9K |
|
2668
CS Disco
LAW
$297M
| $192K | ﹤0.01% |
32,180
+4,632
| +17% | +$32K |
|
2669
Sportsman's Warehouse
SPWH
$46.8M
| $191K | ﹤0.01% |
79,426
+19,237
| +32% | +$61.1K |
|
2670
Sotera Health
SHC
$5.43B
| $188K | ﹤0.01% |
15,852
-601
| -4% | -$6.86K |
|
2671
Krispy Kreme
DNUT
$569M
| $185K | ﹤0.01% |
+17,181
| New | +$213K |
|
2672
Monte Rosa Therapeutics
GLUE
$1.35B
| $185K | ﹤0.01% |
49,410
+15,562
| +46% | +$79.3K |
|
2673
Pulmonx
LUNG
$92.8M
| $184K | ﹤0.01% |
28,954
+1,272
| +5% | +$9.78K |
|
2674
Shattuck Labs
STTK
$735M
| $183K | ﹤0.01% |
47,367
+9,608
| +25% | +$78.1K |
|
2675
GrowGeneration
GRWG
$108M
| $182K | ﹤0.01% |
84,823
+12,197
| +17% | +$30.9K |
|
Similar funds
American Century Companies's Q2 2024 Portfolio in Review
As of Q2 2024, American Century Companies held 3,009 positions worth $163B, up 2.7% from $159B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
American Century Companies's Q2 2024 filing shows 89 new, 1,863 increased, 760 reduced and 131 closed positions. Its largest new stake was UL Solutions: 1,631,475 shares worth $68.8M. The largest sale was UnitedHealth, an estimated $387M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2024 buy was UL Solutions: 1,631,475 shares worth $68.8M.
- American Century Companies added most to iShares Russell 1000 Growth ETF in Q2 2024, an estimated $510M increase.
- American Century Companies's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $387M.
- American Century Companies fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $235M.
- American Century Companies's ten largest holdings make up 27% of its $163B portfolio in Q2 2024.
- American Century Companies opened 89 new positions and closed 131 in Q2 2024.
- American Century Companies's portfolio value rose 2.7% quarter-over-quarter to $163B.
Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.